|Page (1) of 1 - 07/06/17||email article||print page|
Earth Science Tech, Inc. Enters into a Joint Venture with Varsity Group, LLC. Under Its Wholly Owned Subsidiary KannaBidioid Inc.(July 06, 2017)
Hollywood, July 06, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCPINK: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices enters into a joint venture with Varsity Group, LLC. under KannaBidioid Inc., to synergistically share resources as well as their patent pending Kanna Blend formula.
ETST’s management team came across an opportunity to step into the Recreational Vape/Smoke space which is projected to spend $4.77 billion by 2025*. Earth Science Tech discovered Varsity Group, LLC ,a Kanna Blend ingredient based E-liquid company that has a Patented Kanna-Blend formula(Kanna Chill), which is produced in their ISO-9001 cGMP Sunrise, FL lab facility. Earth Science Tech and Varsity Group, LLC have joined forces to formulate KannaBlend-Infused Hemp Derived Naturally occurring cannabidiol (CBD) based E-liquid/Sublingual and Gummy Edibles, hence KannaBidioid, Inc. (KBD). This new exciting First To Market Joint Venture will be a 50/50 partnership, with both revenue and expenses being shared equally. Both parties will be exclusive to each other and work synergistically sharing their resources to be the leading innovative E-liquid/Sublingual and Gummy Edible supplier in this space.
Varsity Group, LLC was co-founded by David Plante, who will be the president overseeing ETST’s new subsidiary KannaBidioid, Inc. Varsity Group, LLC sets the example for being a world class manufacture for the best E-liquid available. Their proven quality control methods, attentiveness to industry regulations, superior customer service, and industry trade secrets consistently keeps the Kanna Chill brand at the pinnacle of industry standards. Varsity Vapes, founded in January 2016 and headquartered in the sunny state of south Florida, is manufactured under stringent FDA guidelines in a ISO-9001 and cGMP certified facility. With previous backgrounds in pharmaceutical manufacturing, business development, and engineering the company strives to produce the highest quality e-liquid formulations. Developed over the past four years, Varsity is proud to be the world’s first, to introduce a choice to the industry, on whether customers want nicotine or an all natural non-addictive alternative to nicotine. They’ve explored and rigorously studied the industry listening to what customers want, inspiring Varsity to incorporate an effective alternative to nicotine within our line. When a customer tries Varsity Vapes Kanna Chill, they can start to comprehend the difference between the high quality Varsity Vapes Kanna Chill line and other sub-par e-juice blends. Their consistency with correctly blending and developing their own flavor formulations illustrates their competitive advantage over this vast industry.
David Plante, Managing Partner and Co-founder of Varsity Group, LLC and ETST KannaBidioid, Inc’s President enthusiastically commented, “I can’t think of a better company to work and join forces with”. Having ETST’s passionate and knowledgeable team, R&D and distribution capabilities, genuine customer service, and brand building skills definitely offers me a team to truly build a brand and lead the recreational vape/smoke shop space. In addition to their top-tier team, their reputation in the CBD space is nothing short of amazing. Their loyal customers, positive feedback, and consistent high quality really make them key, and I couldn’t feel more fortunate to take part and grow along with them.”
Nickolas S. Tabraue, ETST’s President, Director, and COO comments, “This joint venture is pivotal for ETST’s entrance to the recreational CBD arena. We can now enter with not only an amazing Kanna Blend and CBD formula, but also a patent-pending tested blend from Varsity Group, LLC. We feel extremely confident knowing that with David Plante overwatching operations, he will help our new subsidiary, KannaBidiod rapidly grow”. We’re currently in the design phase with Varsity Group’s strong moving flavors, Strawberry Lemonade, Apple Pie, Lemon Cream, and Grape Berry. We then will commence marketing, manufacturing, and distribution within 3Q2017.”
ETST continuously plans on updating its shareholders on the above mentioned new subsidiary, joint venture, and sales as further progress and development occurs.
About Earth Science Tech, Inc. (ETST): Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world's best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil. T
To learn more please visit: www.earthsciencetech.com
ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality and purity of High Grade Hemp CBD (Cannabidiol) Oil. ETST's primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural-Organic Hemp CBD Oil while never compromising on quality. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Wellness benefits. With no psychoactive ingredient, Hemp CBD Oil is a ready-for-market Hemp-based Nutraceutical. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach. CBD (cannabidiol), a naturally occurring constituent of the Industrial Hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants." ETST does not grow, sell or distribute any substances that violate United States Law or the controlled substance act. ETST does sell and distribute cannabis industrial hemp based products.
View ETST's accomplishments and reports on its High-Grade CBD Hemp Oil: (here)
About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.
To learn more please visit: www.Earthsciencepharmaceutical.com
The accuracy of the MSN-2 medical device for the diagnosis of women with Chlamydia has already been proven via a study of 510 female patients, which showed PCR testing results on paired samples to be identical for 493 (96.6%) of the 510 women. To view this study, visit Evaluation of a Modified Sanitary Napkin as a Sample Self-Collection Device for the Detection of Genital Chlamydial Infection in Women.
About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.
To learn more please visit: www.Cannabisthera.com
Some of the R&D that Cannabis Therapeutics will target will be treatments for the conditions and disorders of: Pain, Chronic Pain, PTSD, Breast Cancer, Brain Cancer, Anxiety, Depression, Glaucoma, Crohn’s disease, Fatty Liver Diseases, Diabetes, Parkinson' s Disease, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), and Drug Addictions among other things. ETST has chosen to target diseases for which, the benefits of Cannabinoids and/or CBD (Cannabidiol) have already been demonstrated by different groups of researchers around the world. However, it is through ETST’s in vitro study with the University of Central Oklahoma and DV Biologics that results confirm the positive effectiveness of Earth Science Tech’s CBD (Cannabidiol) on breast cancer, immune cell function, and human brain cells by acting as a neuroprotectant as shown in its International Application (PCT) for its Provisional Patent. Thus, as a result by mixing natural molecules and generic pharmaceutical drugs with Cannabinoids and/or CBD (Cannabidiol) we intend to increase the effectiveness of Cannabinoids and/or CBD (Cannabidiol) and improve the treatment of different diseases. The THREE (3) cannabis cannabinoid-based nutraceutical patents and TWO (2) generic pharmaceutical drugs will be based on ETST’s International Application (PCT) for its Provisional Patent named “Cannabidiol Compositions Including Mixtures and Uses Thereof” was filed on October 8th, 2015 in regards to its Cannabis Hemp CBD (Cannabidiol) Oil. This application claims the benefit of ETST U.S. Provisional Application N. 62/061,577, filed October 8, 2014 and ETST U.S. Provisional Application No. 62/102,538, filed January 12, 2015.
About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it's unique Kanna Blend and CBD formula. Kanna and CBD synergistically enahnce enhance one another, providing optimal relaxation, an uplifiting uplifting sensation, enahnce increase focus, and help ease with nicotine addiction based on their properties properties.
Website coming soon: www.kannabidioidinc.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Investor Relations Dave Demarest (305)-546-7640 Earth Science Tech, Inc. Nickolas S. Tabraue, P/D/COO (305)-615-2118